FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030637643> ?p ?o ?g. }

• W2030637643 endingPage "164" @default.
• W2030637643 startingPage "155" @default.
• W2030637643 abstract "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa. They do not require routine coagulation monitoring. However, in special clinical settings (emergency surgery, bleeding, thrombosis, control of the patient's compliance, suspected overdose, potential drug interference, and so on), measurement of plasma levels is needed. Several available anti-FXa assays are used for monitoring anticoagulant activity of heparins and fondaparinux. They must be modified and standardized for the measurement of direct FXa inhibitors (rivaroxaban, apixaban, edoxaban, betrixaban and others). The use of calibrators (lyophilized plasma with a known concentration of drug) allows an expression of the results in ng per ml of plasma. Two categories of assays - endogenous and exogenous assays are available. Endogenous assays are useful in pharmaceutical research, while exogenous assays are used in clinical laboratories. The preferred anti-FXa assay is a specific method in contrast to prothrombin time and activated partial thromboplastin time, but it is not available everywhere at any time. A specific measurement of direct FXa inhibitors is feasible with the use of a new test developed by the authors' group. The physicians must be aware of the possibility to measure the plasma concentration of FXa inhibitors in patients at high risk of bleeding and in several other special clinical situations." @default.
• W2030637643 created "2016-06-24" @default.
• W2030637643 creator A5000669194 @default.
• W2030637643 creator A5051037168 @default.
• W2030637643 creator A5055065274 @default.
• W2030637643 creator A5057790688 @default.
• W2030637643 creator A5070686719 @default.
• W2030637643 date "2013-04-01" @default.
• W2030637643 modified "2023-09-25" @default.
• W2030637643 title "Monitoring plasma levels of factor Xa inhibitors: how, why and when?" @default.
• W2030637643 cites W1923759825 @default.
• W2030637643 cites W1967239537 @default.
• W2030637643 cites W1998354077 @default.
• W2030637643 cites W2016578538 @default.
• W2030637643 cites W2019960723 @default.
• W2030637643 cites W2020148377 @default.
• W2030637643 cites W2030594826 @default.
• W2030637643 cites W2030772055 @default.
• W2030637643 cites W2034802719 @default.
• W2030637643 cites W2035435004 @default.
• W2030637643 cites W2036007875 @default.
• W2030637643 cites W2036451082 @default.
• W2030637643 cites W2045987573 @default.
• W2030637643 cites W2054022967 @default.
• W2030637643 cites W2054730686 @default.
• W2030637643 cites W2055169746 @default.
• W2030637643 cites W2058280673 @default.
• W2030637643 cites W2060202760 @default.
• W2030637643 cites W2064826963 @default.
• W2030637643 cites W2075398576 @default.
• W2030637643 cites W2075502536 @default.
• W2030637643 cites W2087630384 @default.
• W2030637643 cites W2103573619 @default.
• W2030637643 cites W2105644555 @default.
• W2030637643 cites W2116930113 @default.
• W2030637643 cites W2132953336 @default.
• W2030637643 cites W2144939065 @default.
• W2030637643 cites W2157224841 @default.
• W2030637643 cites W2160547102 @default.
• W2030637643 cites W2335009931 @default.
• W2030637643 doi "https://doi.org/10.1586/ehm.13.11" @default.
• W2030637643 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23547865" @default.
• W2030637643 hasPublicationYear "2013" @default.
• W2030637643 type Work @default.
• W2030637643 sameAs 2030637643 @default.
• W2030637643 citedByCount "34" @default.
• W2030637643 countsByYear W20306376432013 @default.
• W2030637643 countsByYear W20306376432014 @default.
• W2030637643 countsByYear W20306376432015 @default.
• W2030637643 countsByYear W20306376432016 @default.
• W2030637643 countsByYear W20306376432017 @default.
• W2030637643 countsByYear W20306376432019 @default.
• W2030637643 countsByYear W20306376432020 @default.
• W2030637643 countsByYear W20306376432022 @default.
• W2030637643 countsByYear W20306376432023 @default.
• W2030637643 crossrefType "journal-article" @default.
• W2030637643 hasAuthorship W2030637643A5000669194 @default.
• W2030637643 hasAuthorship W2030637643A5051037168 @default.
• W2030637643 hasAuthorship W2030637643A5055065274 @default.
• W2030637643 hasAuthorship W2030637643A5057790688 @default.
• W2030637643 hasAuthorship W2030637643A5070686719 @default.
• W2030637643 hasConcept C126322002 @default.
• W2030637643 hasConcept C144594695 @default.
• W2030637643 hasConcept C16124881 @default.
• W2030637643 hasConcept C2776301958 @default.
• W2030637643 hasConcept C2776877702 @default.
• W2030637643 hasConcept C2778205648 @default.
• W2030637643 hasConcept C2778261982 @default.
• W2030637643 hasConcept C2778382381 @default.
• W2030637643 hasConcept C2778661090 @default.
• W2030637643 hasConcept C2778810321 @default.
• W2030637643 hasConcept C2779161974 @default.
• W2030637643 hasConcept C2780035454 @default.
• W2030637643 hasConcept C2780290652 @default.
• W2030637643 hasConcept C2780638905 @default.
• W2030637643 hasConcept C2780868729 @default.
• W2030637643 hasConcept C2991741193 @default.
• W2030637643 hasConcept C71924100 @default.
• W2030637643 hasConcept C98274493 @default.
• W2030637643 hasConceptScore W2030637643C126322002 @default.
• W2030637643 hasConceptScore W2030637643C144594695 @default.
• W2030637643 hasConceptScore W2030637643C16124881 @default.
• W2030637643 hasConceptScore W2030637643C2776301958 @default.
• W2030637643 hasConceptScore W2030637643C2776877702 @default.
• W2030637643 hasConceptScore W2030637643C2778205648 @default.
• W2030637643 hasConceptScore W2030637643C2778261982 @default.
• W2030637643 hasConceptScore W2030637643C2778382381 @default.
• W2030637643 hasConceptScore W2030637643C2778661090 @default.
• W2030637643 hasConceptScore W2030637643C2778810321 @default.
• W2030637643 hasConceptScore W2030637643C2779161974 @default.
• W2030637643 hasConceptScore W2030637643C2780035454 @default.
• W2030637643 hasConceptScore W2030637643C2780290652 @default.
• W2030637643 hasConceptScore W2030637643C2780638905 @default.
• W2030637643 hasConceptScore W2030637643C2780868729 @default.
• W2030637643 hasConceptScore W2030637643C2991741193 @default.
• W2030637643 hasConceptScore W2030637643C71924100 @default.
• W2030637643 hasConceptScore W2030637643C98274493 @default.
• W2030637643 hasIssue "2" @default.

• next